Axis-Shield grants Hycor rights to its anti-cyclic citrullinide (CCP) biomarker to diagnose rheumatoid arthritis

Axis-Shield plc

U.K. / Medical Devices and Diagnostics

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Hycor Biomedical Inc.

U.S. / Medical Devices and Diagnostics

$46.6m on 06/04/2004 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced